GlobalData on MSN5d
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
Newsweek11d
Most Trusted Brands Ranking Highlights Consumer Desire for Affordability
Languages: English, Italian People are increasingly careful about where they spend their money, and they want to be sure the brands they choose will provide quality products at fair prices and a ...
Contract Pharma5d
AbbVie’s EMBLAVEO Approved by FDA for Treatment of Complicated Intra-Abdominal Infections
Addresses the significant threat of antimicrobial resistance.
FiercePharma5d
AbbVie scores FDA nod for Pfizer-partnered antibiotic Emblaveo
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
Monthly Prescribing Reference9d
Emblaveo Approved for Intra-Abdominal Infections in Patients With Limited Options
Approval of this indication is based on limited clinical safety and efficacy data for Emblaveo. In REVISIT, study participants with cIAI (n=312) were randomly assigned 2:1 to receive aztreonam ...
Forbes25d
16 Value Propositions To Make Your Brand A 2025 Standout
Your brand's ability and willingness to solve pain points for current and potential customers can make or break your company's existence and relevance in the industry. To help brand leaders remain ...
Healio9d
FDA approves Emblaveo for complicated intra-abdominal infections
Please provide your email address to receive an email when new articles are posted on . Emblaveo is the first monobactam/beta-lactamase inhibitor and antibiotic combination approved for this ...
Forbes29d
Brand Content’s Best Signals An Entertainment-Driven Future
As we enter 2025, it is clearer than ever that in the back half of this decade, brand building and audience engagement will be rooted in the creation of brand-funded content and entertainment.